| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 08/01/2006 | US7083794 Selecting for a strain of bacteria having an RpoS+ phenotype, inactivating mutations which render the strain attenutated, and a recombinant gene encoding the product |
| 08/01/2006 | US7083784 Molecules with extended half-lives, compositions and uses thereof |
| 08/01/2006 | CA2250714C Animal cells and processes for the replication of influenza viruses |
| 08/01/2006 | CA2192073C Novel oligosaccharide derivatives, preparation method therefor and uses thereof |
| 08/01/2006 | CA2176720C Novel enzyme inhibitors, their synthesis, and methods for use |
| 07/27/2006 | WO2006079015A2 Quorum sensing modulators |
| 07/27/2006 | WO2006078975A2 Improved vaccine against feline calicivirus |
| 07/27/2006 | WO2006078904A2 Use of tetrazole derivatives as quorum sensing modulators |
| 07/27/2006 | WO2006078317A1 Substituted quinobenzoxazine analogs and methods of using thereof |
| 07/27/2006 | WO2006078213A1 Vaccine composition comprisinga fibronectin binding protein or a fibronectin binding peptide |
| 07/27/2006 | WO2006078066A1 Transbronchial remedy for respiratory infection |
| 07/27/2006 | WO2006078032A1 Anti-penicillin resistant pneumococci agent and novel 16-membered ring macrolide derivative |
| 07/27/2006 | WO2006077984A1 Fluoroalkylpyrrolidine derivative |
| 07/27/2006 | WO2006077499A1 Chemical compounds |
| 07/27/2006 | WO2006077427A2 Antiviral drug combinations |
| 07/27/2006 | WO2006077139A2 Peptide deformylase inhibitors, their use, and pharmaceutical compositions containing the same |
| 07/27/2006 | WO2006060712A9 Potassium salt of an hiv integrase inhibitor |
| 07/27/2006 | WO2006050250A3 Dose forms comprising vx-950 and their dosage regimen |
| 07/27/2006 | WO2006044582A3 Use of baff to treat sepsis |
| 07/27/2006 | WO2005117904A3 Phosphonate analogs of hiv integrase inhibitor compounds |
| 07/27/2006 | WO2005114206A3 Diagnostics and therapeutics for diseases associated with serotonin 5-ht5a receptor (5ht5a) |
| 07/27/2006 | WO2005020894A3 Rifamycin analogs and uses thereof |
| 07/27/2006 | US20060168682 Plant peptide with antimicrobial activity |
| 07/27/2006 | US20060167267 Michael-type addition of a nucleophile to a dialkyl 2-methylidenylpropan-1,3-dioate and the conversion of a ester moiety into an amino moiety; S)-2-methylcysteine; desferrithiocin |
| 07/27/2006 | US20060167261 e.g. N-(4-Chloro-3-trifluoro methyl phenyl)-2-[3-(4-pyridinyloxy)phenyl amino]-acetamide; serine/threonine kinase inhibitor; anticarcinogenic, antiproliferative, antidiabetic agent; autoimmune diseases; atherosclerosis, arthritis, Crohn's disease, retinopaty |
| 07/27/2006 | US20060167253 substituted diaminopyrimidine compounds having HIV inhibiting properties; reacting 4-(2-cyanoethenyl)-2,6-dimethylbenzenamine with an intermediate (4-cyano, 2-pyrimidine- aniline derivative; reaction with acrylonitril |
| 07/27/2006 | US20060167252 Imidazo[1,2-a]pyridine derivatives for treatment of herpes viral infections |
| 07/27/2006 | US20060167055 Non-nucleoside reverse transcriptase inhibitors |
| 07/27/2006 | US20060167052 Piperidine derivative, process for producing the same, and use |
| 07/27/2006 | US20060167049 Terphenly derivatives, preparation thereof, compositions containing same |
| 07/27/2006 | US20060167048 N-4-piperidinyl compounds as ccr5 modulators |
| 07/27/2006 | US20060167043 Isoquinoline derivatives having kinasae inhibitory activity and drugs containing the same |
| 07/27/2006 | US20060167041 Imidazopyridine compound |
| 07/27/2006 | US20060167034 Novel benzonaphthyridines |
| 07/27/2006 | US20060167010 Phenylahistin and the phenylahistin analogs, a new class of anti-tumor compounds |
| 07/27/2006 | US20060167002 Aza-bicycloalkyl ethers and their use as alpha7-nachr agonists |
| 07/27/2006 | US20060167001 Pyridazinone-derivatives as pde4 inhibitors |
| 07/27/2006 | US20060166978 Inhibitors of IkB kinase (I Kappa B Kinase); 1-acetyl-7-bromo- beta -carboline; antiinflammatory and anticarcinogenic agent; asthma, osteoarthritis, rheumatoid arthritis, Alzheimer's disease, infections, and cardiac infarct |
| 07/27/2006 | US20060166976 Compositions and methods for treating or preventing convulsions or seizures |
| 07/27/2006 | US20060166961 Cell adhesion inhibitors |
| 07/27/2006 | US20060166946 Methods of preparing substituted tetracyclines with transition metal-based chemistries |
| 07/27/2006 | US20060166943 Microbicidal pyrimidine or triazine for preventing sexual hiv transmission |
| 07/27/2006 | US20060166940 Such as (R)-2-amino-2-methyl-4-[4-(4,4,5,5,5-pentafluoro-pentyloxy)-phenyl]-butan-1-ol hydrochloride for treatment of disorders or diseases mediated by lymphocytes, and for treating acute or chronic transplant rejection or T-cell-mediated inflammatory or autoimmune diseases |
| 07/27/2006 | US20060166927 Compounds that bind to the interferon-gamma, preparation method thereof and medicaments containing same |
| 07/27/2006 | US20060166895 N-heterocyclic hydroxyethylamine compounds; human immunodeficiency virus (HIV) protease |
| 07/27/2006 | US20060166869 Novel use of lipopeptide preparations |
| 07/27/2006 | US20060166865 A modified nucleoside comprising a purine ring for treating viral infections |
| 07/27/2006 | US20060166341 Method for reproducing pleuromutilins |
| 07/27/2006 | US20060166193 Binding protein |
| 07/27/2006 | US20060166187 Hbv precore protein capable of forming particles |
| 07/27/2006 | US20060165816 Herbal compositions useful as chemopreventive and therapeutic agents |
| 07/27/2006 | US20060165744 Combination liposomal formulations |
| 07/27/2006 | US20060165728 Campylobacter glycans and glycopeptides |
| 07/27/2006 | US20060165727 Vaccine; inducing an immune response; infectious diseases, which can be caused by more than one strain, clade, variant, subtype or serotype of infectious disease causing microorganism; reliable vaccination against all Dengue virus serotypes |
| 07/27/2006 | US20060165714 Peptides for vaccination against human CMV |
| 07/27/2006 | US20060165704 Methods for the treatment of an infectious bacterial disease with an anti-lactone or lactone derived signal molecules antibody |
| 07/27/2006 | US20060165690 Vaccine comprising an antigen conjugated to low valency anti-cd40 or anti-cd28 antibodies |
| 07/27/2006 | US20060165689 Compositions and methods for modulation of effects on phagocyte and lymphoid cell populations employing tirc7 |
| 07/27/2006 | US20060165669 establishing a healthy bacterial flora in females, comprising administering a therapeutically effective amount of a first probiotic Lactobacillus iners; reducing the risk of bacterial vaginosis |
| 07/27/2006 | US20060165664 Method of inducing an enhanced immune response against hiv |
| 07/27/2006 | US20060165650 Rantes-derived peptides with anti-hiv activity |
| 07/27/2006 | CA2595574A1 Chemical compounds |
| 07/27/2006 | CA2595534A1 Improved vaccine against feline calicivirus |
| 07/27/2006 | CA2595481A1 A tetracycline metal complex in a solid dosage form |
| 07/27/2006 | CA2595458A1 Peptide deformylase inhibitors, their use, and pharmaceutical compositions containing the same |
| 07/27/2006 | CA2594567A1 Fluoroalkylpyrrolidine derivative |
| 07/27/2006 | CA2592627A1 Vaccine composition comprising a fibronectin binding protein or a fibronectin binding peptide |
| 07/27/2006 | CA2575547A1 Substituted quinobenzoxazine analogs and methods of using thereof |
| 07/27/2006 | CA2567446A1 Alphavirus vectors for respiratory pathogen vaccines |
| 07/27/2006 | CA2563823A1 Beta-peptides |
| 07/27/2006 | CA2562685A1 Single-stranded and double-stranded oligonucleotides comprising a 2-arylpropyl moiety |
| 07/26/2006 | EP1683526A1 Aqueous solution preparation containing aminoglycoside antibiotic and bromfenac |
| 07/26/2006 | EP1683521A1 Peptide deformylase inhibitors, their use, and pharmaceutical compositions containing the same |
| 07/26/2006 | EP1682564A1 METHODS FOR PREPARING 7-(2 -SUBSTITUTED-s-D-RIBOFURANO SYL)-4-(NR2R3)-5-(SUBSTITUTED ETHYN-1-YL)-PYRROLO 2,3-D|PYRIMIDINE DERIVATIVES |
| 07/26/2006 | EP1682563A1 Bifunctional macrolide heterocyclic compounds and mehtods of making and using the same |
| 07/26/2006 | EP1682556A2 Polymorphous forms of rifaximin as antibiotics |
| 07/26/2006 | EP1682547A1 Rsv polymerase inhibitors |
| 07/26/2006 | EP1682545A1 Imidazopyridine substituted tropane derivatives with ccr5 receptor antagonist activity for the treatment of hiv and inflammation |
| 07/26/2006 | EP1682518A1 Dicationic triaryl analogs as anti-protozoan agents |
| 07/26/2006 | EP1682486A1 Quaternary amino-functional chalcones |
| 07/26/2006 | EP1682165A1 Use of interferon-tau in medicine |
| 07/26/2006 | EP1682163A1 Proteins involved in quorum sensing |
| 07/26/2006 | EP1682146A1 Antimycotic nail polish formulations comprising substituted 2-aminothiazoles as an active substance |
| 07/26/2006 | EP1682076A2 Inhibitors of coronavirus protease and methods of use thereof |
| 07/26/2006 | EP1682072A2 AChE ANTISENSE DEOXYOLIGONUCLEOTIDE AS AN ANTI-INFLAMMATORY AGENT |
| 07/26/2006 | EP1681922A2 Method for treating athlet s foot |
| 07/26/2006 | EP1513839B1 3-substituted quinuclidines and their use |
| 07/26/2006 | EP1414447B1 Use of thiazole derivatives for preparing a medicine for protecting mitochondria |
| 07/26/2006 | EP1397105B1 Compositions for inhibiting angiogenesis |
| 07/26/2006 | EP1390543B1 New polynucleotides and polypeptides of the ifnalpha-17 gene |
| 07/26/2006 | EP1381686B1 Inactivation of genes of the mep pathway |
| 07/26/2006 | EP1353687B1 Methods for obtaining inhibitors of tirc7 ligand binding and uses thereof |
| 07/26/2006 | EP1240313B1 Homologue enzymes of human heparanase and splice variants thereof |
| 07/26/2006 | EP1231933B1 An aqueous solution formulation of alpha-interferon |
| 07/26/2006 | EP1189915B1 Process for the production of azithromycin |
| 07/26/2006 | EP1047454B1 Methods of screening compounds useful for prevention of infection or pathogenicity |
| 07/26/2006 | EP0967991B1 Infectious bursitis vaccine |
| 07/26/2006 | EP0758396B1 Feline immunodeficiency virus vaccine |
| 07/26/2006 | CN1809594A Disialoundecasaccharide chain asparagine/fatty acid amide and medical drug containing the same |
| 07/26/2006 | CN1809551A Flavanone compound and uses thereof |